ABT — Abbott Laboratories Share News
0.000.00%
- $163.94bn
- $191.33bn
- $44.33bn
RBC finds Abbott Q1 readthrough positive for Dexcom, Edwards
Abbott defeats lawsuit alleging Similac contaminated by heavy metals (updated)
U.S. RESEARCH ROUNDUP-Adobe, Chevron, Exxon Mobil
Abbott defeats lawsuit alleging Similac contaminated by heavy metals (updated)
U.S. STOCKS ON THE MOVE-Netflix, J.B. Hunt, Arxis
U.S. STOCKS ON THE MOVE-Abbott, J.B. Hunt, Myseum
Abbott defeats lawsuit alleging Similac contaminated by heavy metals
Abbott hits 2-year low after trimming 2026 earnings forecast
U.S. STOCKS ON THE MOVE-Abbott, PepsiCo, Blue Owl
Abbott slips after trimming 2026 earnings forecast
Abbott results beat on medical device boost, Exact deal hits forecast (updated)
Abbott first-quarter results beat on cancer diagnostics, medical device strength
What to Watch in the Day Ahead - Thursday, April 16
Jury orders Abbott to pay $70 million in preterm infant formula trial, company says (updated)
Jury orders Abbott to pay $53 million in preterm infant formula trial, media report says
Media: Abbott jury awards at least $53 million in infant-formula trial- Bloomberg News
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
U.S. STOCKS ON THE MOVE-Hims & Hers, Chewy, Longeveron
U.S. STOCKS ON THE MOVE-Delta, Levi's, banks